000 | 01846 a2200505 4500 | ||
---|---|---|---|
005 | 20250513120723.0 | ||
264 | 0 | _c19970605 | |
008 | 199706s 0 0 eng d | ||
022 | _a1042-8194 | ||
024 | 7 |
_a10.3109/10428199609093433 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMatherly, L H | |
245 | 0 | 0 |
_aMethotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia. _h[electronic resource] |
260 |
_bLeukemia & lymphoma _cMay 1996 |
||
300 |
_a359-68 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacokinetics |
650 | 0 | 4 | _aBiological Transport |
650 | 0 | 4 | _aBiotransformation |
650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aChromosomes, Human, Pair 21 _xgenetics |
650 | 0 | 4 | _aDisease Susceptibility |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 |
_aDown Syndrome _xcomplications |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 |
_aFolic Acid Antagonists _xpharmacokinetics |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMembrane Proteins |
650 | 0 | 4 | _aMembrane Transport Proteins |
650 | 0 | 4 |
_aMethotrexate _xpharmacokinetics |
650 | 0 | 4 |
_aNeoplasm Proteins _xmetabolism |
650 | 0 | 4 |
_aNeoplastic Stem Cells _xmetabolism |
650 | 0 | 4 |
_aPolyglutamic Acid _xmetabolism |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aReduced Folate Carrier Protein |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 |
_aTetrahydrofolate Dehydrogenase _xmetabolism |
700 | 1 | _aTaub, J W | |
773 | 0 |
_tLeukemia & lymphoma _gvol. 21 _gno. 5-6 _gp. 359-68 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/10428199609093433 _zAvailable from publisher's website |
999 |
_c9153912 _d9153912 |